Emmessar Biotech and Nutrition Ltd
BSE:524768
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Emmessar Biotech and Nutrition Ltd
BSE:524768
|
IN |
|
J
|
Jiachen Holding Group Ltd
HKEX:1937
|
CN |
|
P
|
Punjab Alkalies and Chemicals Ltd
BSE:506852
|
IN |
|
Transmissora Alianca de Energia Eletrica SA
BOVESPA:TAEE3
|
BR |
|
Fasadgruppen Group AB (publ)
STO:FG
|
SE |
|
P
|
PT Nusantara Sawit Sejahtera Tbk
IDX:NSSS
|
ID |
|
Gray Television Inc
NYSE:GTN
|
US |
|
M
|
Mag Magna Corp
OTC:MGNC
|
US |
|
H
|
Hcd Investment Producing and Trading JSC
VN:HCD
|
VN |
|
Spartan Delta Corp
TSX:SDE
|
CA |
|
Procter & Gamble Health Ltd
NSE:PGHL
|
IN |
|
A
|
Apotea AB (publ)
STO:APOTEA
|
SE |
|
N
|
National Plastic Technologies Ltd
BSE:531287
|
IN |
|
U
|
United Overseas Bank Ltd
F:UOB
|
SG |
|
S
|
Sea Ltd
SWB:931
|
SG |
|
Neuroone Medical Technologies Corp
NASDAQ:NMTC
|
US |
Bankruptcy Probability
Emmessar Biotech and Nutrition Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Emmessar Biotech and Nutrition Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
|
Emmessar Biotech and Nutrition Ltd
BSE:524768
|
124.7m INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Emmessar Biotech and Nutrition Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Emmessar Biotech and Nutrition Ltd has no debt.
You can find a full breakdown on its Balance Sheet.
